|
1
|
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
|
Nat Biotechnol
|
2002
|
2.77
|
|
2
|
Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays.
|
Clin Vaccine Immunol
|
2006
|
1.50
|
|
3
|
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
|
J Virol
|
2005
|
1.42
|
|
4
|
Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues.
|
J Virol
|
2007
|
1.41
|
|
5
|
Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region.
|
Infect Immun
|
2005
|
1.28
|
|
6
|
Protection against lethal challenge by Ebola virus-like particles produced in insect cells.
|
Virology
|
2008
|
1.22
|
|
7
|
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.
|
Vaccine
|
2007
|
1.13
|
|
8
|
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.
|
Vaccine
|
2008
|
1.09
|
|
9
|
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
|
Virology
|
2006
|
1.06
|
|
10
|
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.
|
Cancer Immunol Immunother
|
2005
|
1.05
|
|
11
|
Combination therapy reduces self-injurious behavior in a chimpanzee (Pan Troglodytes Troglodytes): a case report.
|
J Appl Anim Welf Sci
|
2007
|
0.96
|
|
12
|
Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons.
|
J Virol
|
2003
|
0.93
|
|
13
|
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.
|
Vaccine
|
2010
|
0.90
|
|
14
|
Pediatric cardiopulmonary bypass adaptations for long-term survival of baboons undergoing pulmonary artery replacement.
|
J Extra Corpor Technol
|
2010
|
0.79
|
|
15
|
Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboons.
|
AIDS Res Hum Retroviruses
|
2003
|
0.76
|